Early Pharmacological Treatment of Type II SMA Patients Slows Scoliosis Progression
A recent study has shed new light on the potential impact of early pharmacological interventions on scoliosis progression in individuals with Type II spinal muscular atrophy (SMA). Scoliosis, affecting up to 90% of Type II SMA cases, poses a significant challenge, and while treatments have shown improvements in motor function, their effect on scoliosis remains […]